Koji Nogami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Koji Nogami has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Hiroto Miwa
Kawanishi City Medical Center
1 shared publication - Kazuko Nagase
Division of Lower Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan
1 shared publication - Ken Fukunaga
Divisions of Lower Gastroenterology
1 shared publication Koji Kamikozuru
Division of Lower Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, 1-1 Mukogawa, Nishinomiya, 663-8501, Hyogo, Japan
1 shared publication- Masaki Iimuro
Division of Lower Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine, 1-1 Mukogawa, Nishinomiya, 663-8501, Hyogo, Japan
1 shared publication - Mikio Kawai
Department of Gastroenterology, Faculty of Medicine, Hyogo Medical University, Nishinomiya 663-8501, Hyogo, Japan
1 shared publication
Latest Publications
- Open Access
- 12 February 2013
- Published by Springer Nature in BMC Gastroenterology
- Vol. 13 (1) , 27
Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA
Adsorptive granulocyte and monocyte apheresis (GMA) with an Adacolumn in patients with ulcerative colitis (UC) has been applied as a non-pharmacological treatment strategy, but the efficacy has been encouraging as well as discouraging, depending on patients’ demography at entry. In this study, we looked for predictive factors for clinical response to GMA in patients with UC.
- 12 February 2013
- Published by Springer Nature in BMC Gastroenterology
- Vol. 13 (1) , 27
Open AccessLooking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA
Adsorptive granulocyte and monocyte apheresis (GMA) with an Adacolumn in patients with ulcerative colitis (UC) has been applied as a non-pharmacological treatment strategy, but the efficacy has been encouraging as well as discouraging, depending on patients’ demography at entry. In this study, we looked for predictive factors for clinical response to GMA in patients with UC.